-
Symbol
-
GLTO on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.00001 par value per share
-
Latest Disclosed Shares Owned
-
120,473 shares
-
Security Ownership %
-
7.5%
Paragon Therapeutics, Inc. ownership in Galecto, Inc. Common Stock, $0.00001 par value per share (GLTO)
12 Jan 2026 - Paragon Therapeutics, Inc. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 120,473 shares of Galecto, Inc. Common Stock, $0.00001 par value per share (GLTO).
This represents 7.5% ownership of the company.
This is the first filing by Paragon Therapeutics, Inc. disclosing ownership of Galecto, Inc. Common Stock, $0.00001 par value per share (GLTO).